Ezgi Yildirim

Ezgi Yildirim

Auto-generated profile, based on publicly available information

Ezgi Yildirim

Institute of Clinical Neurobiology, University Hospital Würzburg 1 , Würzburg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2023 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
LHLuisa Hennlein
Luisa Hennlein
HGHanaa Ghanawi
Hanaa Ghanawi
FGFlorian Gerstner
Florian Gerstner
EGEduardo Palominos García
Eduardo Palominos García
EYEzgi Yildirim
Ezgi Yildirim
SJSibylle Jablonka
Sibylle Jablonka
Plastin 3 (PLS3) is an F-actin-bundling protein that has gained attention as a modifier of spinal muscular atrophy (SMA) pathology. SMA is a lethal pediatric neuromuscular disease caused by loss of or mutations in the Survival Motor Neuron 1 (SMN1) gene. Pathophysiological hallmarks are cellular maturation defects of motoneurons prior to degeneration. Despite the observed beneficial modifying effect of PLS3, the mechanism of how it supports F-actin-mediated cellular processes in motoneurons is not yet well understood. Our data reveal disturbed F-actin-dependent translocation of the Tropomyosin receptor kinase B (TrkB) to the cell surface of Smn-deficient motor axon terminals, resulting in reduced TrkB activation by its ligand brain-derived neurotrophic factor (BDNF). Improved actin dynamics by overexpression of hPLS3 restores membrane recruitment and activation of TrkB and enhances spontaneous calcium transients by increasing Cav2.1/2 “cluster-like” formations in SMA axon terminals. Thus, our study provides a novel role for PLS3 in supporting correct alignment of transmembrane proteins, a key mechanism for (moto)-neuronal development.